Pfizer has a huge pipeline of new drugs that can hit the market in the next few years (sigvotatug vedotin for non-small cell lung cancer ... and PCV-25 for pneumococcal disease, to name a few ...

Vaxcyte (PCVX, 4.3% weighting in the Portfolio) is a leader in novel vaccine chemistry, which has enabled it to create a broad coverage pneumococcal vaccine (PCV) that is unlikely to be matched by ...

From a tiny sample of tissue no larger than a grain of sand, scientists have come within reach of a goal once thought unattainable: building a complete functional wiring diagram of a portion of the ...

Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat ...

For the first time, scientists have built a detailed, interactive map of a human cell, revealing how thousands of proteins ...

The cells kept dying. Paleontologist Kyoko Hagino ... But in this case, the process led to the nitroplast, and the structure is responsible for pumping significant amounts of nitrogen into the ...

Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine ... such as KEYTRUDA for renal cell carcinoma and locally recurrent triple ...

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

Artificial bacterial transformation is a laboratory technique scientists use to introduce foreign DNA into bacterial cells. There are two main methods ... double-stranded DNA (dsDNA). Figure 1: A ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer that forms in your white blood cells called lymphocytes. These cells are made by your lymphatic system, which plays an important role in immunity.

The fall in PCVX shares was further amplified by mixed results from a mid-stage study on its pneumococcal vaccine ... and shaping regulatory pathways for cell and gene therapies, his exit raises ...